LATA KOIRALA: Open Payments
NPI 1639569577 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 46 payments from 10 companies in 2025. Trend: 2023 $2,091 · 2024 $1,823 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $509 |
| Regeneron Healthcare Solutions, Inc. | 4 | $91 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $48 |
| Janssen Scientific Affairs, LLC | 1 | $40 |
| Celltrion USA Inc. | 2 | $34 |
| QOL Medical, LLC | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: RINVOQ, LINZESS, DUPIXENT, TREMFYA, SKYRIZI, CREON, ZENPEP, VEGZELMA.
Industry payments across OK — which companies pay providers there.
